A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Clinical trial NCT07161544 · RECRUITING
Trial details
- NCT number
- NCT07161544
- Sponsor
- AAVantgarde Bio Srl
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-29
- Primary completion
- 2032-07-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.